"What is the risk of taking oral contraceptives in patients with a history of migraine with transient neurological signs?" A woman with a history of migraine associated with hemiparaesthesia, and possibly dysphasia, attended her general practitioner suffering from irregular and frequent menstrual cycles. The doctor considered treatment with oral contraceptives to control her cycles and possibly relieve her migraine attacks. He asked about the risk of treatment with oral contraceptives, compared with no treatment, in a patient with transient neurological signs associated with migraine.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case control study. The World Health Organisation collaborative study of cardiovascular disease and steroid hormone contraception. BMJ 1999; 318: 13-18.
- 2. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case control study of migraine and risk of ischaemic stroke in young women. BMJ 1995; 310: 830-833.
- 3. Schwartz SM, Petitti DB, Siscovick DS, et al. Stroke and use of low dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke 1998; 29: 2277-2284.
- 4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 505-510.
This search was conducted as part of a project supported by a General Practice Evaluation Project grant, GPEP 720, the AQUA project, from the Commonwealth Department of Health and Aged Care. Information about the project, including clinical questions and answers, can be found at